Local consolidative therapy does not improve survival after dual immunotherapy in metastatic NSCLC

Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or progression-free…

Continue in Briflio to read, react, comment, and share.